Take our user survey and make your voice heard.

Health minister to consider U.S. drug firms' views in pricing overhaul

By Tetsushi Kajimoto and Yoshifumi Takemoto

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© (c) Copyright Thomson Reuters 2017.

©2024 GPlusMedia Inc.

Login to comment

Wont happen.

1 ( +1 / -0 )

Big Pharma ought to sent packing. We do not need America's exorbitantly high medical cost to come to Japan. As marcelito above says, we residents of Japan come first, not Big Parma's profits. Anyone want to argue about that?

3 ( +3 / -0 )

I trust the US pharma industry about as far as I can throw them.

1 ( +1 / -0 )

They could start by banning doctors from prescribing medicine that people can buy over the counter. Then maybe limit non critical patent visits to twice a month instead of the standard every five days.

Oh and, screw the global drug companies and their overpriced drugs. More countries need to set the prices like Japan does.

2 ( +2 / -0 )

I wonder if they were considering asking Martin Shkreli for advice ?

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites